Elza DeBruin
10PUBLICATIONS
94CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Apr 22, 2025
The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer.Valentina Cutano, Ming Li Chia, Eleanor M Wigmore
|Jan 09, 2025
Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer.Mitchell J Elliott, Karen Howarth, Sasha Main
|Jul 02, 2024
mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of PIK3CA-Altered Tumors.Constance A Sobsey, Bjoern C Froehlich, Georgia Mitsa
|Jun 13, 2024
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.Sebastijan Hobor, Maise Al Bakir, Crispin T Hiley
|Sep 19, 2023
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.Lorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson
Pageof 2
Frequent Collaborators
4 joint publications
Simon T Barry
4 joint publications
Susana Ros
4 joint publications
Stuart C Williamson
4 joint publications
Lorna Hopcroft
3 joint publications
Larissa S Carnevalli
2 joint publications
Julian Downward
1 joint publications
Paul D Smith
1 joint publications
Nicholas C Turner
1 joint publications
Ana Lluch
1 joint publications
T Hedley Carr